Work

747-P: Insulin Therapy Deintensification with iGlarLixi (IDEAL) Randomized Controlled Trial—CGM-Related Outcomes

Year: 2024

Type: article

Source: Diabetes

DOI: 10.2337/db24-747-p

Authors: PETER NOVODVORSKY, LENKA THIEME, IVANA LANKOVA, ALICA VESELÁ, EMIL ZAHUMENSKY, TOMAS EDELSBERGER, MARIE LÖBLOVÁ, FILIP HRUBÝ, MILOS MRAZ, MARTIN HALUZIK

Language: English

Topic: Diabetes Management and Research

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399687283

FWCI:

Cites:

Cited by:

Related to: 10